Patents by Inventor Akihiro Mimura

Akihiro Mimura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210278243
    Abstract: It is an object of the present invention to perform the same processing in an area determination for a link group consisting of links connecting the same two points. An area determination device includes a map data acquisition unit for acquiring map data including a plurality of link data each representing a link connecting two points on a road map, an area specification unit for specifying any area on the road map, and an area determination unit for performing an area determination on whether the link is an intra-area link which is included in a specified area or an extra-area link which is not included in the specified area, collectively in a link group consisting of links each connecting the same two points as the link does, and the link data are processed in accordance with a result of the area determination.
    Type: Application
    Filed: April 18, 2017
    Publication date: September 9, 2021
    Applicant: MITSUBISHI ELECTRIC CORPORATION
    Inventor: Akihiro MIMURA
  • Patent number: 10894790
    Abstract: Provided is a production method of a thiazole derivative represented by the formula (I), which has an adenosine A2A receptor antagonistic action and is useful as a therapeutic agent for, for example, Parkinson's disease, sleep disorder, analgesic resistance to opioid, migraine, movement disorder, depression, anxiety disorder and the like. Also provided is a production method of a compound represented by the formula (C), which contains (i) a step of reacting a compound represented by the formula (A) and a compound represented by the formula (B), and the like: (wherein R1 represents furyl, R4, R5 and R6 are the same or different and each represents lower alkyl or aryl, R2 represents pyridyl or tetrahydropyranyl, and X1 represents halogen).
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: January 19, 2021
    Assignee: KYOWA KIRIN CO., LTD
    Inventors: Takamasa Sugita, Arata Yanagisawa, Iwao Chujo, Masashi Taga, Akihiro Mimura, Atsushi Tada, Masashi Aoki
  • Publication number: 20200216438
    Abstract: Provided is a production method of a thiazole derivative represented by the formula (I), which has an adenosine A2A receptor antagonistic action and is useful as a therapeutic agent for, for example, Parkinson's disease, sleep disorder, analgesic resistance to opioid, migraine, movement disorder, depression, anxiety disorder and the like. Also provided is a production method of a compound represented by the formula (C), which contains (i) a step of reacting a compound represented by the formula (A) and a compound represented by the formula (B), and the like: (wherein R1 represents furyl, R4, R5 and R6 are the same or different and each represents lower alkyl or aryl, R2 represents pyridyl or tetrahydropyranyl, and X1 represents halogen).
    Type: Application
    Filed: March 18, 2020
    Publication date: July 9, 2020
    Inventors: Takamasa Sugita, Arata Yanagisawa, Iwao Chujo, Masashi Taga, Akihiro Mimura, Atsushi Tada, Masashi Aoki
  • Patent number: 10618894
    Abstract: Provided is a production method of a thiazole derivative represented by the formula (I), which has an adenosine A2A receptor antagonistic action and is useful as a therapeutic agent for, for example, Parkinson's disease, sleep disorder, analgesic resistance to opioid, migraine, movement disorder, depression, anxiety disorder and the like. Also provided is a production method of a compound represented by the formula (C), which contains (i) a step of reacting a compound represented by the formula (A) and a compound represented by the formula (B), and the like: (wherein R1 represents furyl, R4, R5 and R6 are the same or different and each represents lower alkyl or aryl, R2 represents pyridyl or tetrahydropyranyl, and X1 represents halogen).
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: April 14, 2020
    Assignee: KYOWA KIRIN CO., LTD.
    Inventors: Takamasa Sugita, Arata Yanagisawa, Iwao Chujo, Masashi Taga, Akihiro Mimura, Atsushi Tada, Masashi Aoki
  • Publication number: 20190144438
    Abstract: Provided is a production method of a thiazole derivative represented by the formula (I), which has an adenosine A2A receptor antagonistic action and is useful as a therapeutic agent for, for example, Parkinson's disease, sleep disorder, analgesic resistance to opioid, migraine, movement disorder, depression, anxiety disorder and the like. Also provided is a production method of a compound represented by the formula (C), which contains (i) a step of reacting a compound represented by the formula (A) and a compound represented by the formula (B), and the like: (wherein R1 represents furyl, R4, R5 and R6 are the same or different and each represents lower alkyl or aryl, R2 represents pyridyl or tetrahydropyranyl, and X1 represents halogen).
    Type: Application
    Filed: January 14, 2019
    Publication date: May 16, 2019
    Inventors: Takamasa Sugita, Arata Yanagisawa, Iwao Chujo, Masashi Taga, Akihiro Mimura, Atsushi Tada, Masashi Aoki
  • Publication number: 20180319279
    Abstract: A passenger state determining unit (12) determines whether a passenger is sleeping, the passenger being a person riding in a vehicle other than a driver. An operation performing unit (20) performs drowsiness prevention operation for preventing the driver from feeling drowsy, when it is determined by the passenger state determining unit (12) that the passenger is sleeping.
    Type: Application
    Filed: March 16, 2016
    Publication date: November 8, 2018
    Applicant: MITSUBISHI ELECTRIC CORPORATION
    Inventors: Kumiko IKEDA, Mitsuo SHIMOTANI, Mengxiong WANG, Akihiro MIMURA
  • Publication number: 20180002326
    Abstract: Provided is a production method of a thiazole derivative represented by the formula (I), which has an adenosine A2A receptor antagonistic action and is useful as a therapeutic agent for, for example, Parkinson's disease, sleep disorder, analgesic resistance to opioid, migraine, movement disorder, depression, anxiety disorder and the like. Also provided is a production method of a compound represented by the formula (C), which contains (i) a step of reacting a compound represented by the formula (A) and a compound represented by the formula (B), and the like: (wherein R1 represents furyl, R4, R5 and R6 are the same or different and each represents lower alkyl or aryl, R2 represents pyridyl or tetrahydropyranyl, and X1 represents halogen).
    Type: Application
    Filed: January 8, 2016
    Publication date: January 4, 2018
    Inventors: Takamasa Sugita, Arata Yanagisawa, Iwao Chujo, Masashi Taga, Akihiro Mimura, Atsushi Tada, Masashi Aoki